Articles with "coli bacteremia" as a keyword



Photo from academic.microsoft.com

A retrospective study on Escherichia coli bacteremia in immunocompromised patients: Microbiological features, clinical characteristics, and risk factors for shock and death

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Laboratory Analysis"

DOI: 10.1002/jcla.23319

Abstract: To evaluate clinical features, bacterial characteristics, and risk factors for shock and mortality of immunocompromised patients with Escherichia coli bacteremia. read more here.

Keywords: factors shock; coli bacteremia; escherichia coli; characteristics risk ... See more keywords
Photo from wikipedia

Escherichia Coli bacteremia and rapidly progressive cellulitis in a child with newly diagnosed nephrotic syndrome

Sign Up to like & get
recommendations!
Published in 2021 at "IDCases"

DOI: 10.1016/j.idcr.2021.e01218

Abstract: Nephrotic syndrome (NS) in children is associated with spontaneous bacterial infections, including peritonitis as well as cellulitis secondary to chronic third-spacing of intracellular fluid. Typical pathogens that cause cellulitis in these patients are gram-positive bacteria… read more here.

Keywords: coli bacteremia; escherichia coli; rapidly progressive; cellulitis ... See more keywords

Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia

Sign Up to like & get
recommendations!
Published in 2020 at "BMC Infectious Diseases"

DOI: 10.1186/s12879-020-05499-1

Abstract: Background It is important to understand clinical features of bacteremic urinary tract infection (bUTI), because bUTI is a serious infection that requires prompt diagnosis and antibiotic therapy. Escherichia coli is the most common and important… read more here.

Keywords: buti; coli bacteremia; age; infection ... See more keywords
Photo by markusspiske from unsplash

A case of SFTS coinfected with E. coli bacteremia

Sign Up to like & get
recommendations!
Published in 2021 at "BMC Infectious Diseases"

DOI: 10.1186/s12879-020-05705-0

Abstract: Background Severe fever thrombocytopenia syndrome virus (SFTSV) is the causative agent of severe fever thrombocytopenia syndrome (SFTS). SFTS is an emerging infectious disease, characterized by high fever, gastrointestinal symptoms, leukopenia, thrombocytopenia, and a high mortality… read more here.

Keywords: sfts coinfected; coli bacteremia; fever thrombocytopenia; case ... See more keywords
Photo by matteo_skyrider from unsplash

Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy

Sign Up to like & get
recommendations!
Published in 2019 at "BMC Research Notes"

DOI: 10.1186/s13104-019-4648-7

Abstract: ObjectiveExtended spectrum β-lactamases (ESBL) producing Enterobacteriaceae predominantly E. coli and K. pneumoniae bacteremia have limited treatment options and high mortality. The objective was to determine the risk factors for in-hospital mortality particularly treatment with carbapenem… read more here.

Keywords: ceftriaxone resistant; resistant coli; coli bacteremia; beta ... See more keywords
Photo from wikipedia

Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan

Sign Up to like & get
recommendations!
Published in 2018 at "PLoS ONE"

DOI: 10.1371/journal.pone.0202276

Abstract: Objectives To identify risk factors and clinical outcomes in patients with bacteremia due to extended-spectrum beta-lactamase (ESBL) or carbapenemase-producing Escherichia coli, as well as to determine the prevalence and genetic background of such isolates. Methods… read more here.

Keywords: carbapenemase producing; coli bacteremia; beta lactamase; esbl ... See more keywords
Photo from wikipedia

Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort

Sign Up to like & get
recommendations!
Published in 2019 at "Infection and Drug Resistance"

DOI: 10.2147/idr.s197735

Abstract: Objectives: On January 18, 2010, a part of the capital region of Denmark shifted the empirical treatment of febrile conditions from cefuroxime to piperacillin/tazobactam. We compare empirical treatment with piperacillin/tazobactam versus cefuroxime for Escherichia coli… read more here.

Keywords: cefuroxime; treatment; empirical treatment; coli bacteremia ... See more keywords